Obesity drug maker Novo Nordisk ousts CEO as competition weighs
Wegovy-maker Novo Nordisk mentioned on Friday its CEO Lars Fruergaard Jorgensen will step down over issues the corporate is dropping ...
Tag: obersity drug
Get the latest financial news, expert analysis, and in-depth reports from The Financial Observer. Stay ahead in the world of finance with up-to-date trends, market insights, and more.